Responsibilities Lead commercial assessments for a broad portfolio of innovations, including therapeutics, diagnostics, and emerging technologies Evaluate market opportunity, competitive positioning, clinical value, and commercialization potential Develop go/no-go recommendations to guide licensing, partnerships, and venture creation decisions Build comprehensive business cases including market sizing, revenue potential, and risk‑adjusted scenarios Conduct competitive benchmarking, deal analysis, and valuation assessments Partner with scientific founders and advisors to shape new company concepts and development strategies Identify key gaps across data, regulatory, IP, and commercialization readiness Create executive‑ready materials including investment memos, pitch decks, and diligence packages Collaborate cross‑functionally with business development, IP, finance, legal, and research teams Support development of standardized frameworks, templates, and assessment methodologies Requirements Master’s degree required; advanced degree (MBA, PhD, MD, PharmD, MPH) strongly preferred 8–12+ years of experience in life sciences commercial strategy, venture creation, biotech/pharma, consulting, or related fields Proven experience developing commercial assessments, investment cases, and revenue models for early‑stage assets Strong analytical, financial modeling, and strategic thinking capabilities Excellent communication skills with the ability to influence senior stakeholders Experience in oncology, precision medicine, diagnostics, AI‑enabled healthcare solutions, or related areas preferred Demonstrated ability to work cross‑functionally in complex, matrixed environments Ability to evaluate early‑stage opportunities with incomplete data and drive actionable insights #J-18808-Ljbffr
